MYRIAD GENETICS, INC.
Net Cash Flow Breakdown
Total Cash from Operations: $119.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $7.5M | 6.3% |
| Other Investing | $59.6M | 49.8% |
| Other Financing | $16.9M | 14.1% |
| Working Capital | $35.7M | 29.8% |
| Net Cash Flow | $0 | 0.0% |
Net Cash Flow Breakdown
Total Cash from Operations: $119.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $7.5M | 6.3% |
| Other Investing | $59.6M | 49.8% |
| Other Financing | $16.9M | 14.1% |
| Working Capital | $35.7M | 29.8% |
| Net Cash Flow | $0 | 0.0% |